Bristol's Yervoy Gets A Bigger Advisory Committee Cushion
This article was originally published in The Pink Sheet Daily
Executive Summary
The melanoma drug goes up for review by the Oncologic Drugs Advisory Committee Feb. 9, more than six weeks before the PDUFA date of March 26.